Klager over reaktioner på injektionsstedet samt hudreaktioner er beskrevet relativt oftere hos patienter ≤ 18 år end hos voksne patienter.
Complaints of injection site reactions and skin reactions are reported relatively more frequently in patients of 18 years of age or less than in adult patients.